Rachael White and Graham Blakey are pleased to announce the launch of PharmaKinetic Ltd. We are ready to support your projects using our PK and clinical pharmacology expertise to unlock your drug’s potential. Between them Rachael and Graham have over 40 years of drug development experience
PharmaKinetic has core competency in the application of PK and DMPK to early phase drug development. The company combines the expertise and networking opportunities from consult2deliver and RW Biosciences.
Interpretation and oversight of clinical pharmacology and DMPK for innovative products is challenging. PharmaKinetic provide an integrated view that has a direct impact on drug development strategy. We achieve this by providing our clients with a personal service, which ensures that the work undertaken meets the needs of the project and wider business goals.
To meet your project needs, we are able to draw upon a network of Associates with expertise in PK analysis and clinical pharmacology.
PharmaKinetic are ideally placed at BioCity, the life science business incubator in Nottingham.
We look forward to working with you.
